These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23750312)

  • 1. Chemically Programmed Antibodies AS HIV-1 Attachment Inhibitors.
    Sato S; Inokuma T; Otsubo N; Burton DR; Barbas CF
    ACS Med Chem Lett; 2013 May; 4(5):460-465. PubMed ID: 23750312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and activities of macromolecule conjugates of the CCR5 antagonist Maraviroc.
    Asano S; Gavrilyuk J; Burton DR; Barbas CF
    ACS Med Chem Lett; 2014 Feb; 5(2):133-137. PubMed ID: 24563723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralization Synergy between HIV-1 Attachment Inhibitor Fostemsavir and Anti-CD4 Binding Site Broadly Neutralizing Antibodies against HIV.
    Zhang Y; Chapman JH; Ulcay A; Sutton RE
    J Virol; 2019 Feb; 93(4):. PubMed ID: 30518644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of small molecular inhibitors targeting HIV-1 gp120-CD4 interaction drived from BMS-378806.
    Liu T; Huang B; Zhan P; De Clercq E; Liu X
    Eur J Med Chem; 2014 Oct; 86():481-90. PubMed ID: 25203778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action.
    Langley DR; Kimura SR; Sivaprakasam P; Zhou N; Dicker I; McAuliffe B; Wang T; Kadow JF; Meanwell NA; Krystal M
    Proteins; 2015 Feb; 83(2):331-50. PubMed ID: 25401969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-lactam-based approach for the chemical programming of aldolase antibody 38C2.
    Gavrilyuk JI; Wuellner U; Barbas CF
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1421-4. PubMed ID: 19181522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thermodynamics of binding of a low-molecular-weight CD4 mimetic to HIV-1 gp120.
    Schön A; Madani N; Klein JC; Hubicki A; Ng D; Yang X; Smith AB; Sodroski J; Freire E
    Biochemistry; 2006 Sep; 45(36):10973-80. PubMed ID: 16953583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of the HIV-1 attachment inhibitor BMS-626529, the active component of the prodrug BMS-663068, against CD4-independent viruses and HIV-1 envelopes resistant to other entry inhibitors.
    Li Z; Zhou N; Sun Y; Ray N; Lataillade M; Hanna GJ; Krystal M
    Antimicrob Agents Chemother; 2013 Sep; 57(9):4172-80. PubMed ID: 23774428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Site-Specific Lysine Arylation as an Alternative Bioconjugation Strategy for Chemically Programmed Antibodies and Antibody-Drug Conjugates.
    Hwang D; Tsuji K; Park H; Burke TR; Rader C
    Bioconjug Chem; 2019 Nov; 30(11):2889-2896. PubMed ID: 31675216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small-molecule HIV-1 gp120 inhibitors to prevent HIV-1 entry: an emerging opportunity for drug development.
    Kadow J; Wang HG; Lin PF
    Curr Opin Investig Drugs; 2006 Aug; 7(8):721-6. PubMed ID: 16955683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Envelope conformational changes induced by human immunodeficiency virus type 1 attachment inhibitors prevent CD4 binding and downstream entry events.
    Ho HT; Fan L; Nowicka-Sans B; McAuliffe B; Li CB; Yamanaka G; Zhou N; Fang H; Dicker I; Dalterio R; Gong YF; Wang T; Yin Z; Ueda Y; Matiskella J; Kadow J; Clapham P; Robinson J; Colonno R; Lin PF
    J Virol; 2006 Apr; 80(8):4017-25. PubMed ID: 16571818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small molecule drug activity in melanoma models may be dramatically enhanced with an antibody effector.
    Popkov M; Rader C; Gonzalez B; Sinha SC; Barbas CF
    Int J Cancer; 2006 Sep; 119(5):1194-207. PubMed ID: 16570283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient chemical approach to bispecific antibodies and antibodies of high valency.
    Gavrilyuk JI; Wuellner U; Salahuddin S; Goswami RK; Sinha SC; Barbas CF
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3716-20. PubMed ID: 19497743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Virtual screening of small molecular HIV-1 entry inhibitor NC-2 targeting gp120 and its action mechanism].
    Duan H; Wang Y; Song D; Chen Z; Qiu J; Lu L; Jiang S; Liu S; Tan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):826-31. PubMed ID: 23803191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small-Molecule CD4 Mimics Containing Mono-cyclohexyl Moieties as HIV Entry Inhibitors.
    Ohashi N; Harada S; Mizuguchi T; Irahara Y; Yamada Y; Kotani M; Nomura W; Matsushita S; Yoshimura K; Tamamura H
    ChemMedChem; 2016 Apr; 11(8):940-6. PubMed ID: 26891461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of small-molecule human immunodeficiency virus type 1 entry inhibitors that target the gp120-binding domain of CD4.
    Yang QE; Stephen AG; Adelsberger JW; Roberts PE; Zhu W; Currens MJ; Feng Y; Crise BJ; Gorelick RJ; Rein AR; Fisher RJ; Shoemaker RH; Sei S
    J Virol; 2005 May; 79(10):6122-33. PubMed ID: 15857997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIV gp120 H375 is unique to HIV-1 subtype CRF01_AE and confers strong resistance to the entry inhibitor BMS-599793, a candidate microbicide drug.
    Schader SM; Colby-Germinario SP; Quashie PK; Oliveira M; Ibanescu RI; Moisi D; Mespléde T; Wainberg MA
    Antimicrob Agents Chemother; 2012 Aug; 56(8):4257-67. PubMed ID: 22615295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors.
    Teixeira C; Serradji N; Maurel F; Barbault F
    Eur J Med Chem; 2009 Sep; 44(9):3524-32. PubMed ID: 19410340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibition of HIV-1 entry with a chemically programmed antibody aided by an efficient organocatalytic synthesis.
    Gavrilyuk J; Uehara H; Otsubo N; Hessell A; Burton DR; Barbas CF
    Chembiochem; 2010 Oct; 11(15):2113-8. PubMed ID: 20845359
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel class of HIV-1 inhibitors that targets the viral envelope and inhibits CD4 receptor binding.
    Wang HG; Williams RE; Lin PF
    Curr Pharm Des; 2004; 10(15):1785-93. PubMed ID: 15180540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.